Weight Loss Drugs: Striking the Balance Between Benefits and Risks

Raja D

Raja D Professor, Department of Community Medicine, Chettinad Hospital & Research Institute, Chettinad Academy of Research & Education, Kelambakkam, Chengalpattu District, Tamil Nadu, India.

Abstract

How to cite this article:
Raja D. Weight Loss Drugs: Striking the Balance Between Benefits and Risks. Chettinad Health City Med J. 2024;13(2):1-3.

DOI: https://doi.org/10.24321/2278.2044.202421

References

Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6(2):187-94. [PubMed] [Google Scholar]

Hendricks EJ. Off-label drugs for weight management. Diabetes Metab Syndr Obes. 2017;10:223-34. [PubMed] [Google Scholar]

Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebocontrolled, phase 3 trial. Lancet. 2011;377(9774):1341-52. [PubMed] [Google Scholar]